Gail Barnum

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

David M. Koelle, Christine M. Posavad, Gail Barnum et al. · Journal of Clinical Investigation · 1998 · 265 citations · Full text

Viral Persistence, Cervical Cancer, Neurovirology +14

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

Stephen E. Straus, Barbara Savarese, Philip R. Krause et al. · The Lancet · 1994 · 206 citations

Vaccination, Vaccine Development, Vaccine Target +9

Famciclovir for the Suppression of Symptomatic and Asymptomatic Herpes Simplex Virus Reactivation in HIV-Infected Persons: A Double-Blind, Placebo-Controlled Trial

Timothy W. Schacker, Hui Hu, David M. Koelle et al. · Annals of Internal Medicine · 1998 · 177 citations

Safety and Efficacy of 0.5% Podofilox Gel in the Treatment of Anogenital Warts

Stephen K. Tyring, Libby Edwards, Lisa Cherry et al. · Archives of Dermatology · 1998 · 98 citations

Protein-Specific Cervical Antibody Responses to Primary Genital Herpes Simplex Virus Type 2 Infections

R Ashley, Lawrence Corey, Julie Dalessio et al. · The Journal of Infectious Diseases · 1994 · 62 citations

Vaccination, Vulvar Diseases, Cancer-associated Virus +13